Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.
in Mar 20, 2023
March 20 2023 at 8:00 am – March 22 at 5:00 pm – UTC+0
Purple Biotech’s CEO Gil Efron is featured in Pharma’s Almanac sharing his insights in a Q&A executive interview. Read the full Q&A here.
in Mar 27, 2023
EXECUTIVE INTERVIEW – Purple Biotech Ltd.: Developing First-In-Class Oncology Therapies
Purple Biotech CEO Gil Efron is featured in Drug Development and Delivery Magazine in a Q&A executive interview. Read the full interview.
in Mar 14, 2023
EXECUTIVE INTERVIEW – Purple Biotech Ltd.: Developing First-In-Class Oncology Therapies
Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.
in Feb 01, 2023
February 6 2023 at 8:00 am – February 7 at 5:00 pm – UTC+0
Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023
in Dec 11, 2022
January 9 2023 at 8:00 am – January 12 at 5:00 pm – UTC+0
CM24, a Novel Anti-CEACAM1 mAb, Suppresses Neutrophil Extracellular Trap (NET)-Induced Migration and Metastasis of Cancer Cells
in Nov 16, 2022
Presented at the AACR special conference: Cancer Metastasis, November, 2022